Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Sharp India Share Price
131.55+1.30 (+1.00%)
+143.57% past 1 Year
News
REC Limited Reports NSE Block Trade Worth Rs 31.11 Crores
Equity
RECLTD
Income Tax Department Searches Park Medi World Corporate Premises
Equity
PARKHOSPS
Poonawalla Fincorp Reports Rs 66.05 Crores NSE Block Trade
Equity
POONAWALLA
JSW Steel Reports Rs 65.62 Crores NSE Block Trade
Equity
JSWSTEEL
JSW Steel Reports Rs 555.17 Crores BSE Block Trade
Equity
JSWSTEEL
Meesho Reports Rs 1167.43 Crores NSE Block Trade At Rs 231.18
Equity
MEESHO
India Ten Year Government Bond Yield Rises To 7.4112 Percent
Currency
Indian Rupee Opens Stronger Against US Dollar At 95.01
Currency
Tata Elxsi Sees Stronger H2 Led By Healthcare And Life Sciences
Equity
TATAELXSI
Bernstein Maintains Buy On Zydus Lifesciences After Fyb206 Review Acceptance
Equity
ZYDUSLIFE
JPMorgan Maintains Neutral Rating On Tata Elxsi With Rs 3,200 Target
Equity
TATAELXSI
JPMorgan Maintains Overweight Rating On ICICI Prudential Life
Equity
ICICIPRULI
Nomura Maintains Buy On ICICI Prudential Life Despite VNB Margin Miss
Equity
HSBC Maintains Buy On ICICI Prudential Life With Rs 582 Target
Equity
ICICIPRULI
Transformers and Rectifiers Reports Strong Order Book Growth
Equity
TARIL
HSBC Retains Buy Rating On Travel Food Services Amid Growth And Renewal Risks
Equity
TRAVELFOOD
Prestige Estates reports strong Q2 presales and hospitality investment
Equity
PRESTIGE
Nomura Retains Buy Rating As Prestige Estates Pre Sales Beat Estimates
Equity
PRESTIGE
Prestige Estates Reports Strong Q2 FY27 Pre Sales And Launch Pipeline
Equity
PRESTIGE
Kotak Maintains Buy On M&M With Rs 4,000 Target Price
Equity
M&M